4,800 Shares in Waters Corporation $WAT Purchased by Grantham Mayo Van Otterloo & Co. LLC

Grantham Mayo Van Otterloo & Co. LLC acquired a new stake in shares of Waters Corporation (NYSE:WAT) in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 4,800 shares of the medical instruments supplier’s stock, valued at approximately $1,439,000.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Mawer Investment Management Ltd. lifted its stake in shares of Waters by 225.5% in the 3rd quarter. Mawer Investment Management Ltd. now owns 1,551,010 shares of the medical instruments supplier’s stock worth $465,008,000 after acquiring an additional 1,074,449 shares during the period. Alliancebernstein L.P. increased its stake in shares of Waters by 31.0% during the second quarter. Alliancebernstein L.P. now owns 4,021,358 shares of the medical instruments supplier’s stock valued at $1,403,615,000 after acquiring an additional 950,687 shares during the period. Massachusetts Financial Services Co. MA raised its holdings in Waters by 44.3% during the third quarter. Massachusetts Financial Services Co. MA now owns 2,689,693 shares of the medical instruments supplier’s stock worth $806,397,000 after purchasing an additional 825,723 shares in the last quarter. Norges Bank bought a new stake in Waters during the second quarter worth approximately $266,384,000. Finally, Veritas Asset Management LLP acquired a new stake in Waters in the third quarter worth approximately $175,320,000. Institutional investors and hedge funds own 94.01% of the company’s stock.

Waters Price Performance

Shares of NYSE:WAT opened at $299.79 on Wednesday. The company has a market capitalization of $29.41 billion, a PE ratio of 27.84, a price-to-earnings-growth ratio of 2.11 and a beta of 1.20. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.27 and a current ratio of 1.73. The stock has a fifty day moving average of $358.17 and a 200-day moving average of $351.75. Waters Corporation has a one year low of $275.05 and a one year high of $414.15.

Waters (NYSE:WAT) last announced its earnings results on Monday, February 9th. The medical instruments supplier reported $4.53 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $4.50 by $0.03. Waters had a return on equity of 34.79% and a net margin of 20.30%.The company had revenue of $932.36 million for the quarter, compared to analyst estimates of $928.17 million. During the same period in the previous year, the firm earned $4.10 earnings per share. Waters’s revenue for the quarter was up 6.9% compared to the same quarter last year. Waters has set its FY 2026 guidance at 14.300-14.500 EPS and its Q1 2026 guidance at 2.250-2.350 EPS. As a group, equities analysts anticipate that Waters Corporation will post 12.86 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

WAT has been the topic of several research analyst reports. Wall Street Zen cut Waters from a “buy” rating to a “hold” rating in a research report on Sunday, February 8th. Wells Fargo & Company cut their price objective on Waters from $415.00 to $355.00 and set an “equal weight” rating for the company in a report on Wednesday, February 11th. Wolfe Research raised Waters from a “peer perform” rating to an “outperform” rating and set a $480.00 target price for the company in a research note on Wednesday, December 10th. William Blair started coverage on shares of Waters in a research report on Monday, January 5th. They issued an “outperform” rating on the stock. Finally, HSBC began coverage on shares of Waters in a report on Tuesday, January 27th. They issued a “buy” rating and a $460.00 price target for the company. Two research analysts have rated the stock with a Strong Buy rating, ten have given a Buy rating and nine have given a Hold rating to the company. According to MarketBeat, Waters has an average rating of “Moderate Buy” and an average target price of $393.84.

About Waters

Waters Corporation is a global provider of analytical instruments, software and services for laboratory and research applications. The company designs, manufactures and sells technologies centered on liquid chromatography, mass spectrometry, separation science, and related sample preparation and detection systems. Its product portfolio includes chromatographs, mass spectrometers, columns and consumables, laboratory informatics and workflow software, as well as technical support and training services that help customers run and interpret complex analyses.

Waters serves a wide range of end markets that include pharmaceutical and biotechnology companies, contract research and testing laboratories, academic and government research institutions, clinical diagnostics, food and environmental testing, and industrial and chemical manufacturers.